A 14-gene panel of immune-related genes (including TNF, CD8A, IFNG, and various chemokines and TLRs) predicted prognosis in early stage but not late stage HCC, suggesting that a protective immune microenvironment can exist in early but not late stage HCC [119]. This evidence concerns the gene IFNG and hepatocellular carcinoma.